Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Okada

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Dermatology|March 8, 2026
A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal LymphopoietinThalita Bastos, Makoto Ito, Masahiro Kamata, et al.
Experimental Dermatology|November 2, 2024
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic DermatitisHideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, et al.
BMJ Open|May 8, 2024
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trialYasuhiro Homma, Takuma Yamasaki, Ken Tashiro, et al.
The Journal of Dermatology|October 21, 2024
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoidShoya Suzuki, Masahiro Kamata, Hideaki Uchida, et al.
The Journal of Dermatology|May 28, 2024
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitorsRyosuke Takeshima, Masahiro Kamata, Shoya Suzuki, et al.
Experimental Dermatology|February 28, 2024
Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitisEmi Sakurai, Masahiro Kamata, Hideaki Uchida, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Dermatology|March 8, 2026
A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal LymphopoietinThalita Bastos, Makoto Ito, Masahiro Kamata, et al.
Experimental Dermatology|November 2, 2024
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic DermatitisHideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, et al.
BMJ Open|May 8, 2024
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trialYasuhiro Homma, Takuma Yamasaki, Ken Tashiro, et al.
The Journal of Dermatology|October 21, 2024
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoidShoya Suzuki, Masahiro Kamata, Hideaki Uchida, et al.
The Journal of Dermatology|May 28, 2024
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitorsRyosuke Takeshima, Masahiro Kamata, Shoya Suzuki, et al.
Experimental Dermatology|February 28, 2024
Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitisEmi Sakurai, Masahiro Kamata, Hideaki Uchida, et al.
Pageof 2